Yebo

Yebo Medicine is a private biotechnology company based in Redwood City, California, dedicated to the development of next-generation therapeutic and diagnostic solutions. Founded in 2021 by Dr. Omid Farokhzad, a prominent biotech entrepreneur and the founder of Seer and BIND Therapeutics, the company operates at the intersection of precision medicine and advanced molecular diagnostics. Yebo Medicine significantly expanded its capabilities through the acquisition of ProterixBio, inheriting a portfolio focused on pulmonary health and high-sensitivity protein detection technologies. While the company remains largely in stealth mode, its mission involves leveraging deep biological insights to address significant unmet needs in respiratory and infectious diseases. The leadership team comprises seasoned experts from the life sciences industry, aiming to integrate diagnostic precision with drug discovery.